SEGMENT REPORTING (Tables)

6 Months Ended

Jun. 30, 2013

Segment Reporting [Abstract]

Schedule of certain information of these segments

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Revenues
Surgical products	$	14,680		$	15,922		$	29,163		$	31,416
Brachytherapy seed		5,975			6,315			11,694			12,635
Intersegment eliminations		(356	)		(281	)		(685	)		(512	)
	$	20,299		$	21,956		$	40,172		$	43,539
Earnings (loss) from operations
Surgical products	$	(31	)	$	588		$	(366	)	$	787
Brachytherapy seed		874			747			1,273			2,127
Transaction expenses		(716	)		—			(716	)		—
Intersegment eliminations		4			(20	)		(43	)		(23	)
	$	131		$	1,315		$	148		$	2,891
Capital expenditures, excluding asset acquisition
Surgical products	$	821		$	411		$	1,233		$	683
Brachytherapy seed		132			242			247			299
	$	953		$	653		$	1,480		$	982
Depreciation and amortization
Surgical products	$	1,207		$	1,214		$	2,443		$	2,443
Brachytherapy seed		767			923			1,535			1,677
	$	1,974		$	2,137		$	3,978		$	4,120

Schedule of supplemental information related to significant assets

	June 30, 2013			December 31, 2012
Identifiable assets
Surgical products	$	70,284		$	70,361
Brachytherapy seed		62,243			62,474
Corporate investment in subsidiaries		111,439			111,439
Intersegment eliminations		(137,193	)		(138,549	)
	$	106,773		$	105,725
Intangible assets
Surgical products	$	5,272		$	6,644
Brachytherapy seed		3,958			4,376
	$	9,230		$	11,020

Schedule of information regarding revenue by geographic regions

	Three Months Ended June 30,				Six Months Ended June 30,
	2013		2012		2013		2012
Product sales
United States	$	16,626	$	17,876	$	32,638	$	36,824
Europe		1,956		2,285		4,159		3,794
Other foreign countries		1,043		1,152		2,040		1,674
		19,625		21,313		38,837		42,292
License and fee income
United States		276		258		544		505
Canada		398		385		791		742
		674		643		1,335		1,247
	$	20,299	$	21,956	$	40,172	$	43,539